Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV tirofiban before endovascular treatment for acute ischemic stroke
ChiCTR-INR-17014167Phase 4Recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ischemic stroke comparing Tirofiban group with Placebo control group (2 arms). Primary endpoints: mRS score at 90 days, Symptomatic intracerebral hemorrhage rate within 48 hours and 1 more. Started Dec 2017; status: recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-INR-17014167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-INR-17014167.